Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01168232 · BASELINE

Baseline characteristics

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer · Source last updated 2019-08-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      34
    units
    Participants
groups
  1. description
    Ixabepilone administered at 40 mg/m2 IV infusion over 3 hours on day 1 of a 21-day cycle until disease progression or adverse effects prohibit further treatment
    id
    BG000
    title
    Ixabepilone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          7.7
          value
          66.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      20-29 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      30-39 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      40-49 years
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          7
      title
      50-59 years
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      60-69 years
    6. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      70-79 years
    7. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      80-89 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
    param Type
    NUMBER
    title
    International Federation of Gynecology and Obstetrics (FIGO) Stage - Recurrent/Persistent
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Carcinosarcoma-heterologus
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Carcinosarcoma-homologous
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Carcinosarcoma, MMT
    param Type
    NUMBER
    title
    Histologic Type
    unit Of Measure
    participants
population Description
Eligible and treated patients
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      34
    units
    Participants
groups
  1. description
    Ixabepilone administered at 40 mg/m2 IV infusion over 3 hours on day 1 of a 21-day cycle until disease progression or adverse effects prohibit further treatment
    id
    BG000
    title
    Ixabepilone
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          7.7
          value
          66.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      20-29 years
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      30-39 years
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      40-49 years
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          7
      title
      50-59 years
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      60-69 years
    6. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      70-79 years
    7. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      80-89 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
    param Type
    NUMBER
    title
    International Federation of Gynecology and Obstetrics (FIGO) Stage - Recurrent/Persistent
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Carcinosarcoma-heterologus
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Carcinosarcoma-homologous
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          6
      title
      Carcinosarcoma, MMT
    param Type
    NUMBER
    title
    Histologic Type
    unit Of Measure
    participants
population Description
Eligible and treated patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice